Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Recurrence × trametinib × Clear all

Sponsor

Conditions

Melanoma 25 Neoplasms 11 Carcinoma, Non-Small-Cell Lung 6 Neoplasm Metastasis 4 Multiple Myeloma 4 Hematologic Neoplasms 4 Lymphoma 3 Brain Neoplasms 3 Biliary Tract Neoplasms 3 Skin Neoplasms 2 Leukemia, Myeloid, Acute 2 Glioma 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Bile Duct Neoplasms 2 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oligodendroglioma 1 Nonseminomatous germ cell tumor 1 Neurofibromatosis 1 1 Neurocytoma 1 Myelodysplastic Syndromes 1 Mouth Neoplasms 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Hairy Cell 1 Klatskin Tumor 1

Interventions

Cyclophosphamide 32 Dexamethasone 30 Rituximab 22 Cytarabine 21 fludarabine phosphate 20 Methotrexate 17 Lenalidomide 17 fludarabine 15 Bortezomib 15 Peripheral Blood Stem Cell Transplantation 14 Calcium Dobesilate 14 Whole-Body Irradiation 13 Mycophenolic Acid 13 Etoposide 13 pembrolizumab 12 Melphalan 12 Filgrastim 12 Paclitaxel 11 Gemcitabine 11 Cyclosporine 11 Carboplatin 11 pomalidomide 10 Busulfan 10 Vincristine 9 carfilzomib 8 Tacrolimus 8 Panobinostat 8 Clofarabine 8 Cetuximab 8 Brentuximab Vedotin 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡